№ files_lp_3_process_7_095660
File format: docx
Character count: 1357
File size: 59 KB
Signature
Note:
EU number
Sponsor(s) of the trial:
Name and address of the company, hospital, university or other organisation
Date:
DD/MMM/YYYY
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2023
Region / City:
Global
Topic:
Coaching, ICF Credentialing
Document Type:
Exam Format
Organization:
International Coach Federation (ICF)
Author:
International Coach Federation (ICF)
Target Audience:
Coaching professionals pursuing ICF certification
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Document type:
Guidance document
Subject:
Informed consent in interventional clinical trials
Population:
Healthy adult participants
Scope:
Interventional clinical trials with trial medicine
Jurisdiction:
Belgium
Organizations mentioned:
CT College; Healixia; Ethics Committees; Belgian Data Protection Authority
Language versions:
English; French; Dutch
Intended users:
Clinical trial sponsors
Regulatory context:
Ethics Committee submission requirements
Version:
1.0
Year:
2023
Region / City:
Global
Topic:
Credentialing, Coaching, Exam Format
Document Type:
Official Announcement
Organization / Institution:
International Coaching Federation (ICF)
Author:
ICF
Target Audience:
Coaching professionals, Credentialing candidates
Effective Date:
February 1, 2023
Scheduled Break Start Date:
February 1, 2023
Change Date:
February 1, 2023
Year:
2021
Region / city:
Global
Topic:
Clinical Decision Making, Physical Therapy
Document Type:
Guide
Author:
Not specified
Target Audience:
Students, Healthcare Professionals
Period of Validity:
Ongoing
Approval Date:
Not specified
Date of Changes:
Not specified
Organization:
International Coaching Federation (ICF)
Document Type:
Sample Agreement
Subject:
Professional Coaching Services
Parties:
Coach; Company Client; Employee Client
Referenced Standard:
ICF Code of Ethics
Effective Date:
To be specified
Jurisdiction:
Not specified
Purpose:
Provision of professional coaching services to selected company employees
Liability Statement:
Disclaimer of warranties and limitation of liability by ICF
Termination:
Subject to terms specified within the Agreement
Confidentiality:
Protection of Employee Client confidentiality and coaching communications
Year:
2026
Region / City:
United States
Topic:
Tax Credit, Employment, Certification
Document Type:
Government Form
Organization:
U.S. Department of Labor, Employment and Training Administration
Author:
U.S. Department of Labor
Target Audience:
Employers, Job Applicants, State Workforce Agencies
Effective Period:
Until March 31, 2026
Approval Date:
Not specified
Revision Date:
Not specified
Document type:
Supplementary table
Subject:
Mapping of ICF categories to Target Outcomes and questionnaires
Classification system:
International Classification of Functioning, Disability and Health (ICF)
Components covered:
Body Function; Activities and Participation
ICF chapters:
b1 Mental functions; b2 Sensory functions and pain; d1 Learning and applying knowledge; d2 General tasks and demands; d3 Communication; d4 Mobility; d5 Self-care; d6 Domestic life; d7 Interpersonal interactions and relationships; d8 Major life areas; d9 Community, social and civic life
Levels included:
Level 2; Level 3–4
Additional section:
Neuropsychological assessment
Source reference:
WHO ICF Browser (https://apps.who.int/classifications/icfbrowser/
Note:
)
Document type:
Sponsor statement template
Subject:
Use of Belgian Model Informed Consent Form for vaccine trials in adult healthy volunteers
Related procedure:
Clinical trial application
Scope:
Interventional trials with investigational vaccines
Geographical reference:
Belgium
Applicable to:
Sponsors of clinical trials
Referenced document:
Belgian Model ICF for Vaccine Trials in Adult Healthy Volunteers
Required information:
EU number, trial number, sponsor details, adaptations to mandatory text if applicable
Signature requirement:
Sponsor representative in the Member State
Date format:
DD/MMM/YYYY
Year:
24
Region / city:
Not specified
Field:
Health and Wellness Coaching
Document type:
Academic Program Requirements
Organization:
Notre Dame of Maryland University
Author:
Not specified
Target audience:
Students enrolled in the Master of Arts in Health and Wellness Coaching
Duration:
Three semesters
Approval date:
Not specified
Modification date:
Not specified
Note:
Year
Topic:
Clinical Trial Agreement
Document Type:
Contract
Institution / Organization:
Istituto clinico Humanitas
Target Audience:
Medical, Scientific, and Research Professionals
Year:
2024
Region / City:
European Union
Subject:
EudraVigilance Registration
Document Type:
Registration Form
Authoring Organisation:
European Medicines Agency (EMA)
Target Audience:
Sponsors of clinical trials
Effective Period:
Not specified
Approval Date:
10 December 2024
Modification Date:
Not specified
Study name:
Abbreviated Title
IND number:
XXXXXX
Regulatory framework:
21 CFR Part 312
Jurisdiction:
United States
Document type:
Sponsor obligation transfer agreement
Transferor:
XYZ Co.
Transferee:
UTSW Medical Center
Involved authorities:
Food and Drug Administration; Drug Enforcement Administration
Scope:
Allocation of sponsor responsibilities for an Investigational New Drug
Signatories:
Current IND Sponsor; New Sponsor
Year:
2024
Region / City:
United States
Theme:
Immigration, Sponsorship
Document Type:
Form
Institution:
U.S. Citizenship and Immigration Services (USCIS)
Author:
U.S. Government
Target Audience:
Immigrants, Sponsors
Effective Period:
Expires 01/31/2026
Approval Date:
01/23/2024
Amendment Date:
N/A
Note:
Contextual description
Year:
2023
Region / City:
Rockville, Maryland
Topic:
Training Activities, Suicide Prevention, Mental Health
Document Type:
Public Report
Organization / Institution:
SAMHSA (Substance Abuse and Mental Health Services Administration)
Author:
SAMHSA
Target Audience:
Training Participants, Mental Health Professionals
Period of Action:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Note:
Contextual Description
Year:
2026
Region / City:
Gyeonggi Province, South Korea
Subject:
Internship program
Document Type:
Proposal
Institution:
Gyeonggido Job Foundation
Author:
Gyeonggido Job Foundation
Target Audience:
Sponsoring organizations
Validity Period:
2026
Approval Date:
N/A
Modification Date:
N/A
Year:
2024
Region / city:
United States
Subject:
Immigration, Affidavit of Support
Document type:
Form Instructions
Agency / institution:
U.S. Citizenship and Immigration Services (USCIS)
Author:
U.S. Department of Homeland Security
Target audience:
Sponsors and household members of intending immigrants
Effective period:
Until 01/31/2026
Approval date:
01/23/2024
Amendment date:
08/07/2024
Year:
2023
Region / City:
N/A
Topic:
Clinical Trials, Sponsor and CRO Engagement
Document Type:
Agenda
Organization / Institution:
N/A
Author:
N/A
Target Audience:
Sponsor and CRO teams
Period of Effect:
N/A
Approval Date:
N/A
Revision Date:
N/A
Year:
2017
Region / City:
Birmingham
Topic:
Clinical Research Oversight
Document Type:
Standard Operating Procedure
Organization / Institution:
University of Birmingham
Author:
Not specified
Target Audience:
Clinical researchers, investigators, institutional oversight committees
Period of Validity:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2023
Region / city:
N/A
Topic:
Clinical Trial Consent
Document Type:
Research Protocol
Organization / Institution:
DF/HCC
Author:
N/A
Target Audience:
Parents or Guardians of Children Participating in Clinical Trials
Effective Period:
N/A
Approval Date:
N/A
Amendment Date:
N/A